OMEPRAZOLE SODIUM BICARBONATE

Generic: OMEPRAZOLE SODIUM BICARBONATE, OMEPRAZOLE AND SODIUM BICARBONATE

Cipla USA Inc.Manufacturer
ORALRoute
OMEPRAZOLEActive Substance
2016-12-06Original Approval

OMEPRAZOLE SODIUM BICARBONATE is FDA application ANDA207476, sponsored by SCIEGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
CHRONIC KIDNEY DISEASE
118 reports
2
DRUG INEFFECTIVE
80 reports
3
ACUTE KIDNEY INJURY
53 reports
4
RENAL FAILURE
53 reports
5
INCORRECT PRODUCT ADMINISTRATION DURATION
41 reports
6
NAUSEA
34 reports
7
HEADACHE
30 reports
8
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
27 reports
9
DYSPNOEA
23 reports
10
DEATH
22 reports